Showing results (391-400 of 599) with videos related to
Sort By:
Pageof 60
Arthritis & Rheumatology (Hoboken, N.J.)|March 7, 2022
Driving Role of Interleukin-2-Related Regulatory CD4+ T Cell Deficiency in the Development of Lung Fibrosis and Vascular Remodeling in a Mouse Model of Systemic SclerosisCamelia Frantz, Anne Cauvet, Aurélie Durand, et al.Chest|October 16, 2022
Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and ResearchAnna-Maria Hoffmann-Vold, Cathrine Brunborg, Paolo Airò, et al.Rheumatology (Oxford, England)|April 9, 2026
18F-fluorodeoxyglucose PET/CT uptake characteristics in ICI-induced polymyalgia rheumatica compared to idiopathic polymyalgia rheumaticaArthur Bouchut, Thibaut Jacquet, Yasmine Gouyette, et al.Journal of Scleroderma and Related Disorders|April 7, 2022
Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definitionCosimo Bruni, Maya H Buch, Daniel E Furst, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|August 21, 2019
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosisVeronica Codullo, Emanuela Cova, Laura Pandolfi, et al.Immunogenetics|July 13, 2006
Evaluation of interleukin 13 polymorphisms in systemic sclerosisBrigitte Granel, Christophe Chevillard, Yannick Allanore, et al.Clinical and Experimental Rheumatology|May 19, 2011
Association study of 3 rheumatoid arthritis risk loci in systemic sclerosis in European Caucasian populationBaptiste Coustet, Philippe Dieude, Julien Wipft, et al.Clinical and Experimental Rheumatology|December 3, 2024
Human epididymitis protein 4 as a biomarker of interstitial lung disease in patients with idiopathic inflammatory myopathiesElisabetta Zanatta, Beatrice Moccaldi, Andrea Martini, et al.The Journal of Rheumatology|March 17, 2010
Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severityPhilippe Dieude, Karen Dawidowicz, Mickaël Guedj, et al.Seminars in Arthritis and Rheumatism|February 6, 2025
Management of disease progression after autologous hematopoietic stem cell transplantation in systemic sclerosis: Results from an international questionnaire-based studyJulia Spierings, Giulia Bandini, Yannick Allanore, et al.Pageof 60